Euronext

Options Appoints Former NYSE Euronext Executive as VP of Software Development

Friday, January 15, 2021 - 12:46pm

Options, the leading provider of cloud-enabled managed services to the global capital markets, has today announced former NYSE Euronext executive, Kieran Northime as VP of Software Development.

Key Points: 
  • Options, the leading provider of cloud-enabled managed services to the global capital markets, has today announced former NYSE Euronext executive, Kieran Northime as VP of Software Development.
  • View the full release here: https://www.businesswire.com/news/home/20210115005283/en/
    Options Appoints Former NYSE Euronext Executive as VP of Software Development (Photo: Business Wire)
    Kieran joins Options with three decades of experience across infrastructure, market data and software development, following roles with Wombat Financial Software, Lehman Brothers, Misys (now Finastra), and at NYSE Euronext, where he was VP of Technology, Exchange Solutions.
  • Prior to Options, Kieran most recently founded bespoke systems solution company, Black Eye Technology.
  • Options was named among the UKs leading growth companies in the 2019, 2018 and 2017 Sunday Times HSBC International Track 200 league table.

VEON appoints Leonid Boguslavsky as director

Friday, January 15, 2021 - 7:00am

AMSTERDAM, Jan. 15, 2021 /PRNewswire/ -- VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announces the appointment of Leonid Boguslavsky to the Group's Board of Directors.

Key Points: 
  • AMSTERDAM, Jan. 15, 2021 /PRNewswire/ -- VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, announces the appointment of Leonid Boguslavsky to the Group's Board of Directors.
  • Prior to becoming a venture capitalist, Mr. Boguslavsky was a managing partner of PwC Management Consulting Services.
  • Commenting on the appointment, Gennady Gazin, Chairman of the VEON Board, said: "I would like to welcome Leonid to the Board of Directors.
  • Forward-looking statements are inherently subject to risks and uncertainties, many of which VEON cannot predict with accuracy and some of which VEON might not even anticipate.

Kiadis draws €20 million from bridge loan with Sanofi

Thursday, January 14, 2021 - 6:00am

Amsterdam, The Netherlands, January 14, 2021 Kiadis Pharma N.V. (Kiadis or the Company) (Euronext Amsterdam and Brussels: KDS) today announces that the Company has drawn 20 million from the Companys bridge loan with Sanofi (the Bridge Loan) to bridge Kiadis capital needs through the closing of the acquisition by Sanofi.

Key Points: 
  • Amsterdam, The Netherlands, January 14, 2021 Kiadis Pharma N.V. (Kiadis or the Company) (Euronext Amsterdam and Brussels: KDS) today announces that the Company has drawn 20 million from the Companys bridge loan with Sanofi (the Bridge Loan) to bridge Kiadis capital needs through the closing of the acquisition by Sanofi.
  • Agreement on its principal terms and the intention to enter into the Bridge Loan were announced on November 2, 2020 and the Bridge Loan has been entered into on January 13, 2021.
  • The Bridge Loan makes available a total of 27.7 million of capital to be borrowed.
  • Further information on the Bridge Loan will be included in the offer memorandum, which is expected to be published in Q1 2021.

ALD: Update on liquidity contract

Thursday, January 14, 2021 - 12:19am

Number of executions on buy side on semester: 1,077

Key Points: 
  • Number of executions on buy side on semester: 1,077
    Number of executions on sell side on semester: 720
    Traded volume on buy side on semester: 231,314 shares for 2,563,587.80
    Traded volume on sell side on semester: 162,325 shares for 1,787,099.53
    * the following resources appeared on the liquidity account when the activity started:
    The liquidity agreement complies with AMF Decision n 2018-01 dated 2nd July 2018, introducing liquidity agreements on equity securities as permitted market practice.
  • As of January 13th, 2021, ALD has terminated the liquidity contract entrusted to Kepler Cheuvreux.
  • As of the termination date, the following resources appeared on the liquidity account:
    From January 14th, 2021, and for a period of one year, renewable by tacit agreement, ALD has entrusted Exane BNP Paribas with the implementation of a liquidity contract covering ALD shares (ISIN code FR0013258662) admitted to trading on Euronext Paris, that complies with the code of ethics issued by AMAFI on March 8, 2011 and approved by Autorit des Marchs Financiers on March 21 of the same year.
  • The following resources have been credited to the liquidity account to fund these market-making transactions:
    In this context, the resources allocated to the liquidity contract have been increased by 500,000.

Redline Brings Ultra-Low latency Execution to EMEA Equities

Tuesday, January 12, 2021 - 7:00am

WOBURN, Mass., Jan. 12, 2021 /PRNewswire-PRWeb/ -- Redline Trading Solutions, the premier provider of high-performance market data and order execution systems for automated trading, announced that the company's ultra-low latency Order Execution Gateway is now available in production for EMEA equities.

Key Points: 
  • WOBURN, Mass., Jan. 12, 2021 /PRNewswire-PRWeb/ -- Redline Trading Solutions, the premier provider of high-performance market data and order execution systems for automated trading, announced that the company's ultra-low latency Order Execution Gateway is now available in production for EMEA equities.
  • Order Execution Gateway now supports MiFID II compliant, ultra-low latency, quote and order execution on EMEA exchanges including the London Stock Exchange, Milan Stock Exchange, Deutsche Brse, Swiss Exchange, Euronext Stock Exchange, CBOE Europe.
  • Redline's Execution Gateway combines high reliability with ultra-low latency quote and order execution to support a variety of trading and order routing applications.
  • Redline and InRush are trademarks of Redline Trading Solutions, Inc.
    Other products mentioned may be trademarks of their respective holders.

Intercontinental Exchange Announces Bakkt to Become a Publicly Traded Company via Merger with VPC Impact Acquisition Holdings

Monday, January 11, 2021 - 1:00pm

The newly combined company will be renamed Bakkt Holdings, Inc. and will be listed on the New York Stock Exchange.

Key Points: 
  • The newly combined company will be renamed Bakkt Holdings, Inc. and will be listed on the New York Stock Exchange.
  • As part of the transaction, Bakkts existing equity holders and management will roll 100% of their equity into the combined company.
  • Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange.
  • Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located at http://www.intercontinentalexchange.com/terms-of-use .

STMicroelectronics Announces Status of Common Share Repurchase Program

Monday, January 11, 2021 - 10:30am

Disclosure of Transactions in Own Shares Period from Jan 04, 2021 to Jan 08, 2021

Key Points: 
  • Disclosure of Transactions in Own Shares Period from Jan 04, 2021 to Jan 08, 2021
    AMSTERDAM January 11, 2021 -- STMicroelectronics N.V. (the Company or STMicroelectronics), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the Program) disclosed via a press release dated November 5, 2018.
  • The Program was approved by a shareholder resolution dated May 31, 2018 and by the supervisory board.
  • STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) (Ticker: STM) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris, in the period between January 04, 2021 to January 08, 2021 (the Period), of 368,618 ordinary shares (equal to 0.04% of its issued share capital) at the weighted average purchase price per share of EUR 32.1798 and for an overall price of EUR 11,862,049.37.
  • Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STM (ISIN: NL0000226223), in detailed form.

2CRSi SA: Half-year statement of the liquidity contract as of December 31, 2020

Thursday, January 7, 2021 - 6:08pm

Founded in Strasbourg (France), 2CRSi group develops, produces and sells high-performance customised and environment-friendly servers.

Key Points: 
  • Founded in Strasbourg (France), 2CRSi group develops, produces and sells high-performance customised and environment-friendly servers.
  • In the financial year 2019/2020, the Group achieved pro forma turnover of 141.1m.
  • The Group today has approximately 350 employees and markets its offer of innovative solutions (processing, storage and network) in more than 50 countries.
  • 2CRSi has been listed since June 2018 on the regulated market of Euronext in Paris (ISIN Code: FR0013341781) and is included in the European Rising Tech label.

TechnipFMC Announces Resumption of Activities Toward Separation into Two Industry-Leading, Independent, Publicly Traded Companies

Thursday, January 7, 2021 - 4:32pm

TechnipFMC will retain the outstanding public and private debt but for the European commercial paper program that will be retained by Technip Energies.

Key Points: 
  • TechnipFMC will retain the outstanding public and private debt but for the European commercial paper program that will be retained by Technip Energies.
  • In advance of the CMD, Technip Energies will publicly file a draft registration statement with the U.S. Securities and Exchange Commission on Form F-1 (the F-1).
  • TechnipFMC will continue to transform the industry through its pioneering integrated delivery model iEPCI, technology leadership and digital innovation.
  • TechnipFMC will remain incorporated in the United Kingdom with headquarters in Houston and listings on both the NYSE and Euronext Paris.

GEN inCode Appoints New Chairman

Thursday, January 7, 2021 - 7:00am

OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 January, 2021.

Key Points: 
  • OXFORD, England, Jan. 7, 2021 /PRNewswire/ -- GEN inCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 January, 2021.
  • Bill Rhodes is a Chairman with a proven, demonstrable international track record in the Life Sciences and Diagnostics industry across NASDAQ, Euronext and AIM-listed public companies, as well as private companies in the U.S., UK and Europe.
  • He is a strategic and commercially focused leader with significant experience at the board level across large and small companies, with specific focus in recent years on diagnostic companies in the small to mid-cap space.
  • Matthew Walls, Chief Executive Officer, said:"We are delighted to welcome Bill to the Company and Board.